Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Metastatic Brain Tumor Trials

PO 5200: Phase II Trial of Chemotherapy with Temozolomide in Combination with Topotecan for CNS Metastases of Solid Tumors using INFOTECH Soft TrialSense Clinical Trials System (IRB: 0407-0032) – Investigator Initiated  

Principal Investigator: Pamela New, M.D.
Study Coordinator: Kimbra Harris Phone Number: 713-441-3800
Description: The purpose of this study is to find out how well Temozolomide and Topotecan work together in the treatment of Central Nervous System (CNS) Metastases of Solid Tumors, and what are the side effects when those drugs are given together.
Status: Active

Ask a question or refer a patient.

LITT Study: Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging (MRI)-Guided Laser Induced Thermal Therapy (LITT) for Treatment of Metastatic Brain Tumors (IRB: 1108-0325) – Visualase Trial

Principal Investigator: Pamela New, M.D.
Sub-Investigator: David Baskin, M.D.
Study Coordinator: Kimbra Harris Phone Number: 713-441-3800
Description: The purpose of this study is to determine the safety and feasibility (reliable performance) of a minimally-invasive laser therapy procedure (Visualase® Thermal Therapy System) to treat cancer that has spread to the brain. The laser device will be used in combination with a magnetic resonance scanner.
Status: Active

Ask a question or refer a patient.

 

How Can We Help?
Call us